Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) shares rose 3.5% during mid-day trading on Monday . The company traded as high as $4.83 and last traded at $4.79. Approximately 41,010 shares changed hands during trading, an increase of 36% from the average session volume of 30,073 shares. The stock had previously closed at $4.63.
Ono Pharmaceutical Price Performance
The firm’s fifty day simple moving average is $4.90 and its 200-day simple moving average is $4.95.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty‐pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co‐developing and commercializing nivolumab (Opdivo), an anti–PD‐1 immune checkpoint inhibitor developed in partnership with Bristol‐Myers Squibb.
Featured Articles
- Five stocks we like better than Ono Pharmaceutical
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
